Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
Drugmakers found a promising cure for the obesity epidemic and their stocks were rewarded for it.
Now, investors are salivating over a new crop of companies tackling a more purely aesthetic problem: baldness.
Read More
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.